DNMT3A and acute myeloid leukemia: Here, using primary AML samples in vitro as well as in an in vivo xenograft model, we investigated whether creno in combination with AZA can eliminate LIC protected by stromal contact in FLT3-mutated AML and determined whether treatment response is dependent on co-existing genetic mutations in DNMT3A, NPM1 and TET2.